Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 167

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions

Open access
Thakur, Shweta, Sarkar, Bibekananda, Cholia, Ravi P, Gautam, Nandini, Dhiman, Monisha, Mantha, Anil K · 2014 · Experimental & Molecular Medicine

Abstract

Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional enzyme involved in the base excision repair (BER) pathway, which repairs oxidative base damage caused by endogenous and exogenous agents. APE1 acts as a reductive activator of many transcription factors (TFs) and has also been named redox effector factor 1, Ref-1. For example, APE1 activates activator protein-1, nuclear factor kappa B, hypoxia-inducible factor 1α, paired box gene 8, signal transducer activator of transcription 3 and p53, which are involved in apoptosis, inflammation, angiogenesis and survival pathways. APE1/Ref-1 maintains cellular homeostasis (redox) via the activation of TFs that regulate various physiological processes and that crosstalk with redox balancing agents (for example, thioredoxin, catalase and superoxide dismutase) by controlling levels of reactive oxygen and nitrogen species. The efficiency of APE1/Ref-1’s function(s) depends on pairwise interaction with participant protein(s), the functions regulated by APE1/Ref-1 include the BER pathway, TFs, energy metabolism, cytoskeletal elements and stress-dependent responses. Thus, APE1/Ref-1 acts as a ‘hub-protein’ that controls pathways that are important for cell survival. In this review, we will discuss APE1/Ref-1’s versatile nature in various human etiologies, including neurodegeneration, cancer, cardiovascular and other diseases that have been linked with alterations in the expression, subcellular localization and activities of APE/Ref-1. APE1/Ref-1 can be targeted for therapeutic intervention using natural plant products that modulate the expression and functions of APE1/Ref-1. In addition, studies focusing on translational applications based on APE1/Ref-1-mediated therapeutic interventions are discussed. Researchers in India review a multifunctional enzyme's role in various human diseases and some plant-derived compounds that may modify its behavior. Apurinic/apyrimidinic endonuclease (APE1) is best known for its role in repairing DNA that has suffered chemical damage. It is also involved in the regulation of gene expression. Anil Mantha and colleagues at the Central University of Punjab have described how these functions contribute to APE1 involvement in various pathologies. For example, while APE1 may help lessen damage to brain cells in neurodegenerative disorders like Alzheimer's disease, its DNA repair activity can protect deadly cancer cells from the lethal effects of chemotherapeutic drugs. Therapeutics that target APE1 are under development. The authors highlight a number of plant-derived compounds such as resveratrol and soy isoflavones that could prove helpful in manipulating APE1 activities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2014.42

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 167

Metadata

Authors
Thakur, S., Sarkar, B., Cholia, R. P., Gautam, N., Dhiman, M., & Mantha, A. K.
Venue
Experimental & Molecular Medicine
Published
2014-07-18
Volume
46
Issue
7
Pages
e106-e106
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W1963552571
Cited by
167
References
20
FWCI
5.35
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions. https://app.cochat.ai/papers/10.1038/emm.2014.42
The paper
Thakur, S., Sarkar, B., Cholia, R. P., Gautam, N., Dhiman, M., & Mantha, A. K. (2014). APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions. Experimental & Molecular Medicine. https://doi.org/10.1038/emm.2014.42

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.